ALERT: Analysis of patients being switched from Warfarin to DOACs

ALERT: Analysis of patients being switched from Warfarin to DOACs

June 22, 2020

Pharmacy contractors requested to submit all EPS anticoagulant prescriptions as soon as possible to aid analysis being done.

LLR LPC alerted pharmacies back in April about the growing number of patients being switched from warfarin to DOACs in the following LLR LPC News article:

Since then, there is still concern around ensuring patients are managing this switch correctly. Contractors are therefore being asked to take additional care with regard to dispensing these medicines.

Analysis is being undertaken centrally to check that patients who are being changed from warfarin to a DOAC are not, inadvertently, being prescribed them both together.

Actions required:

  1. To help this analysis contractors are requested to submit all EPS anticoagulant prescriptions as soon as possible after dispensing, preferably not waiting until the end of the month.
  2. It will also be good practice for a double check to be made with the patient and their SCR to ensure they understand what the medications are and that they are not using warfarin and a DOAC together.

The switch to DOACs and movement away from warfarin, where appropriate, was initially triggered during the COVID-19 crisis in order to reduce the required attendance at INR checks.


Further guidance for across the LLR geographical area was provided by the LMSG and shared with in the following LLR LPC News article:

 



Posted in:


More Latest News >

UPDATES: Medicines Supply Notifications

Alliance Calcium Syrup® and DDAVP® (Desmopressin) 0.01% w/v (100mcg/ 1ml) intranasal solution. Please find attached two Medicine Supply Notifications issued...